Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-22-002127
Filing Date
2022-03-10
Accepted
2022-03-10 20:13:46
Documents
1
Period of Report
2022-03-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 11017
  Complete submission text file 0001179110-22-002127.txt   12376
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Issuer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RANI THERAPEUTICS HOLDINGS, INC. 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address
Farquharson Andrew (Reporting) CIK: 0001865699 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40672 | Film No.: 22730832